Shennon Biotechnologies

Developer of immune cell therapies against solid tumors and autoimmune disease

placeSan Francisco, California, United States calendar_todayFounded 2021 groups8 employees language shennonbio.com

Social engagement

Social engagement: 3.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include DCVC.

Investor typeCountShare
Venture capital4100%

Hiring activity

Hires periodically

12 roles tracked across 5 of the last 12 months

26 Jun 2026 · Associate Scientist · San Francisco, California

26 Jun 2026 · Senior Scientist · San Francisco, California

16 Jun 2026 · Research Associate/Senior Research Associate · San Francisco, California

7 Jun 2026 · Summer PhD/MBA Intern - Oncology Market Analysis and Research · San Francisco

15 May 2026 · Summer MBA Intern - Market Analysis and Research (Oncology/Autoimmune) · San Francisco

Based on job postings tracked across public sources.

Coming soon